MDT - Medtronic plc


97.27
-0.200   -0.206%

Share volume: 1,978,993
Last Updated: 12-24-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: 0.00%

PREVIOUS CLOSE
CHG
CHG%

$97.47
-0.20
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
45%
Profitability 41%
Dept financing 19%
Liquidity 25%
Performance 61%
Company vs Stock growth
vs
Performance
5 Days
-0.45%
1 Month
-7.38%
3 Months
3.24%
6 Months
12.87%
1 Year
19.20%
2 Year
18.19%
Key data
Stock price
$97.27
P/E Ratio 
25.22
DAY RANGE
$97.00 - $97.60
EPS 
$3.71
52 WEEK RANGE
$79.29 - $106.33
52 WEEK CHANGE
$20.47
MARKET CAP 
120.149 B
YIELD 
3.01%
SHARES OUTSTANDING 
1.282 B
DIVIDEND
$0.71
EX-DIVIDEND DATE
12-26-2025
NEXT EARNINGS DATE
08-19-2025
BETA 
0.32
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$6,055,057
AVERAGE 30 VOLUME 
$5,866,625
Company detail
CEO: Geoffrey S. Martha
Region: US
Website: medtronic.com
Employees: 95,000
IPO year: 1981
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies. It operates through four segments: Cardiovascular, Neuroscience, Medical Surgical Portfolio, and Diabetes Operating Unit. The Neuroscience Portfolio segment offers products for spinal surgeons, neurosurgeons, neurologists; neurologists, pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists.

Recent news